Thomas R. Staab II
2015
In 2015, Thomas R. Staab II earned a total compensation of $1.3M as Senior Vice President and Chief Financial Officer at BioCryst Pharmaceuticals, a 38% decrease compared to previous year.
Compensation breakdown
| Option Awards | $796,417 |
|---|---|
| Salary | $411,084 |
| Stock Awards | $108,224 |
| Other | $13,250 |
| Total | $1,328,975 |
Staab received $796.4K in option awards, accounting for 60% of the total pay in 2015.
Staab also received $411.1K in salary, $108.2K in stock awards and $13.3K in other compensation.
Rankings
In 2015, Thomas R. Staab II's compensation ranked 6,560th out of 13,638 executives tracked by ExecPay. In other words, Staab earned more than 51.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,560 out of 13,638 | 52nd |
Division Manufacturing | 2,463 out of 5,190 | 53rd |
Major group Chemicals And Allied Products | 890 out of 1,854 | 52nd |
Industry group Drugs | 713 out of 1,528 | 53rd |
Industry Biological Products, Except Diagnostic Substances | 124 out of 254 | 51st |
Source: SEC filing on April 12, 2017.
Staab's colleagues
We found four more compensation records of executives who worked with Thomas R. Staab II at BioCryst Pharmaceuticals in 2015.
2015
Lynne Powell
BioCryst Pharmaceuticals
Senior Vice President and Chief Commercial Officer
2015
Jon Stonehouse
BioCryst Pharmaceuticals
Chief Executive Officer
2015
William Sheridan
BioCryst Pharmaceuticals
Chief Medical Officer
2015
Yarlagadda Babu
BioCryst Pharmaceuticals